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OBJECTIVES The objective of this study was to determine whether diastolic dysfunction is associated with
increased risk of nonvalvular atrial fibrillation (NVAF) in older adults with no history of atrial
arrhythmia.
BACKGROUND Few data exist regarding the relationship between diastolic function and NVAF.
METHODS The clinical and echocardiographic characteristics of patients age 65 years who had an
echocardiogram performed between 1990 and 1998 were reviewed. Exclusion criteria were
history of atrial arrhythmia, stroke, valvular or congenital heart disease, or pacemaker
implantation. Patients were followed up in their medical records to the last clinical visit or
death for documentation of first AF.
RESULTS Of 840 patients (39% men; mean [ SD] age, 75  7 years), 80 (9.5%) developed NVAF
over a mean ( SD) follow-up of 4.1  2.7 years. Abnormal relaxation, pseudonormal, and
restrictive left ventricular diastolic filling were associated with hazard ratios of 3.33 (95%
confidence interval [CI], 1.5 to 7.4; p  0.003), 4.84 (95% CI, 2.05 to 11.4; p  0.001), and
5.26 (95% CI, 2.3 to 12.03; p  0.001), respectively, when compared with normal diastolic
function. After a number of adjustments, diastolic function profile remained incremental to
history of congestive heart failure and previous myocardial infarction for prediction of NVAF.
Age-adjusted Kaplan-Meier five-year risks of NVAF were 1%, 12%, 14%, and 21% for
normal, abnormal relaxation, pseudonormal, and restrictive diastolic filling, respectively.
CONCLUSIONS The presence and severity of diastolic dysfunction are independently predictive of first
documented NVAF in the elderly. (J Am Coll Cardiol 2002;40:1636–44) © 2002 by the
American College of Cardiology Foundation
In the face of a burgeoning older population, the prevalence
of atrial fibrillation (AF), which is associated with marked
morbidity, mortality, and socioeconomic burden (1–4), is
rapidly increasing. Together with congestive heart failure
(CHF) and type 2 diabetes mellitus, AF constitutes one of
the three growing epidemics in the twenty-first century
(5,6). Demographically, the decline in rheumatic heart
disease in the developed world has shifted the etiology
toward a preponderance of nonvalvular AF (NVAF) (7),
which is one of the most powerful independent risk factors
for stroke (8,9) and is responsible for 75,000 strokes
annually in the U.S. Although diastolic dysfunction (10)
and AF (3) are both age-related conditions, the relationship
between diastolic function and the development of NVAF
has not been defined. The objective of this study was to
determine whether diastolic dysfunction is associated with
increased risk of NVAF in elderly subjects with no prior
history of atrial arrhythmias.
METHODS
Study design and population. A cohort design was used in
this study. After the study was approved by the Mayo
Foundation Institutional Review Board, a list of potential
subjects was identified from the computerized echocardiog-
raphy database. This list included all residents of Olmsted
County, Minnesota, who underwent at least one transtho-
racic echocardiogram at Mayo Clinic (Rochester, Minneso-
ta), Olmsted Medical Center (Rochester, Minnesota), or
their affiliated hospitals between January 1, 1990, and
December 31, 1998, and who were at least 65 years old on
the day of the procedure. Mayo Clinic and its two affiliated
hospitals, together with Olmsted Medical Center and its
affiliated hospital, provide 95% of the medical care deliv-
ered to Olmsted County residents (11). Consequently, the
population from which the sample was drawn included
nearly all elderly Olmsted County residents referred for a
transthoracic echocardiogram during the period of interest.
A total of 6,078 Olmsted County residents, age 65
years, underwent transthoracic echocardiography during the
period studied. For patients who had more than one
echocardiogram performed, the earliest examination within
the study period was designated as the baseline study. The
list of patients was cross-referenced with the computerized
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Mayo Clinic registration file, medical index (containing
diagnostic codes), surgical database, and electrocardio-
graphic database. Excluded were 1,772 patients who, on or
before the date of the baseline echocardiogram, had a
diagnosis of AF or other atrial arrhythmia, stroke (any type),
congenital heart anomaly, or had undergone cardiac valve
surgery or permanent pacemaker implantation. Also ex-
cluded were 182 patients who denied access to their medical
records for research purposes. From the remaining 4,124
potential subjects, a random sample of 2,200 (53%) was
drawn by SAS random number selection. Retrospective
comprehensive review of the Mayo Clinic medical records
of these 2,200 patients was undertaken. During this review,
an additional 1,360 patients were excluded because they
were found to have exclusion criteria (124 patients), more
than mild valvular disease by echocardiographic criteria (929
patients), or had not (or could not) have assessments of
transmitral flow velocities, left atrial (LA) volume, or body
surface area for indexing LA volume (307 patients). The
remaining 840 patients constituted the study population.
Clinical and echocardiographic data. The medical records
of each of the 840 patients were reviewed for data on age,
gender, weight, height, and clinical risk factors. The defi-
nition of coronary artery disease (CAD) included a history
of treated angina, a clinical diagnosis of myocardial infarc-
tion (MI), any coronary revascularization procedure, or the
presence of 50% stenoses in any of the three major
coronary arteries or their larger branches by angiography.
Valvular heart disease was defined by the presence of more
than mild stenosis or regurgitation of any valve. Smoking
status was classified as never, past (quit smoking6 months
earlier), or current. Hyperlipidemia was defined by docu-
mentation of the diagnosis in the history, current or past use
of a lipid-modifying agent, a fasting total cholesterol level of
200 mg/dl, or a low-density lipoprotein cholesterol level
of 130 mg/dl on at least two occasions. Hypertension was
defined as documentation of the clinical diagnosis and/or
use of antihypertensive medications. Diabetes mellitus was
defined by the documented clinical diagnosis or treatment
with oral hypoglycemic agents or insulin. Family history of
CAD referred to the reported presence in first-degree
relatives of CAD or angina requiring treatment, MI, coro-
nary artery bypass graft surgery, or percutaneous translumi-
nal coronary angioplasty. Chronic obstructive pulmonary
disease was defined by the clinical diagnosis documented in
the medical record.
Maximal LA volume was measured offline using the
biplane area-length method (12–14) and also was indexed
by body surface area (indexed LA volume). The cardiolo-
gists measuring LA volume were blinded to the outcome of
the study, namely, the development of NVAF. All other
echocardiographic data were retrieved electronically from
the computerized echocardiographic database. These data
included M-mode LA dimension, left ventricular (LV)
end-systolic and end-diastolic dimensions, LV mass in-
dexed to height, LV ejection fraction, LV fractional short-
ening, LV stroke volume, cardiac index, tricuspid regurgi-
tation velocity, and transmitral flow profile, including peak
E velocity, peak A velocity, E/A ratio, and mitral early
deceleration time (DT). Unlike other transmitral flow
parameters, isovolumic relaxation time was not routinely
measured and, therefore, not used for analyses.
The transmitral Doppler flow profile is integral to the
assessment of diastolic function (15). Early transmitral flow
begins after the pressure in the LV falls below that in the
LA and accelerates to a peak velocity, which is expressed as
peak E. As the atrioventricular pressure gradient falls, mitral
inflow decelerates, and the duration of the deceleration
process is defined by DT. A period of diastasis follows,
during which atrial and ventricular pressures remain approx-
imately equal. Atrial contraction produces another forward
pressure gradient, and the peak velocity achieved is ex-
pressed as peak A.
Conventionally, abnormal relaxation is considered the
mildest form of diastolic dysfunction (grade I) (15). In our
study the presence of mitral E/A 0.75 or DT 240 ms
was considered evidence of abnormal relaxation. In a more
severe stage of diastolic dysfunction with pseudonormal LV
filling (grade II), the transmitral flow characteristics are
similar to those in patients with normal diastolic function.
However, patients with this abnormality generally have
elevated LV filling pressures with an enlarged LA. In this
study, both pseudonormal and normal LV filling were
defined by the presence of mitral E/A of 0.75 to 1.50 and
DT of 151 to 240 ms, but distinguished by whether LA
volume was 28 ml/m2 (pseudonormal) or 28 ml/m2
(normal) (16). Restrictive diastolic filling (grade III, revers-
ibly restrictive; grade IV, irreversibly restrictive) is associated
with markedly elevated LV filling pressures and is the most
severe form of diastolic dysfunction (14,15). In this study
the presence of mitral E/A 1.5 or DT 150 ms were
considered evidence of this abnormality. Due to the retro-
spective nature of the study, we were not able to reliably
differentiate reversible versus irreversible restrictive physiology.
Outcome determination. The outcome of interest,
namely, first documented NVAF, was defined by the first
presentation of AF that was clinically documented by a
physician. All cases of AF had to be confirmed by electro-
cardiogram (ECG). The ascertainment of AF was accom-
plished through review of the medical record of each patient
Abbreviations and Acronyms
AF  atrial fibrillation
CAD  coronary artery disease
CHF  congestive heart failure
DT  deceleration time
LA  left atrium or left atrial
LV  left ventricle or left ventricular
MI  myocardial infarction
NVAF  nonvalvular atrial fibrillation
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and examination of the ECGs accompanying the diagnosis.
As part of quality assurance of the medical review, the list of
patients with the outcome event based on clinical documen-
tation was cross-referenced with medical index diagnostic
code, International Classification of Diseases 9th revision
(ICD-9) 427.31, and with the ECG database. The same
ascertainment criteria were applied to all patients. Transient
postoperative AF, occurring as an isolated episode within
one month after surgery, was not counted as an outcome
event. Because newly documented NVAF, not the duration
or persistence of the arrhythmia, was the outcome event of
interest, no distinction was made between paroxysmal and
persistent NVAF.
Statistical methods. Differences in baseline characteristics
between patients who did and did not develop NVAF after
baseline echocardiography were assessed using chi-square
analyses for categorical variables and rank sum tests for
continuous variables. Descriptive statistics for both groups
were tabulated as means and SD or frequency percentages.
Simple and multiple Cox proportional hazards analyses
were used to estimate the simple and joint associations
among clinical variables, echocardiographic variables, and
the risk of NVAF. The set of variables was reduced by
forward stepwise algorithm until only those significant at
p  0.05 remained in the multivariate model. From these
models, hazard ratios (HR), 95% confidence intervals (CI),
and the associated p values were generated.
The age-adjusted effects of indexed LA volume tertiles
and diastolic function categories on the risk of NVAF were
also assessed by an age-stratified weighted Kaplan-Meier
and log-rank procedure, with weights reflecting the age
stratum proportions in the overall sample (Figs. 1 and 2).
To evaluate the incremental prognostic value of LA volume
and diastolic function profile, the global log likelihood ratio
chi-square statistics for models developed using: 1) clinical
risk factors alone; 2) clinical risk factors plus log (LA
volume); 3) clinical risk factors plus diastolic function
profile; and 4) clinical risk factors plus diastolic function
profile and log (LA volume) were determined by Cox
proportional hazards regression and depicted graphically
(Fig. 3). Because LA volume had a highly skewed distribu-
tion, logarithmic transformation was performed, resulting in
more normally distributed data for statistical modeling. In
all cases, statistical significance was defined as two-tailed
p  0.05.
RESULTS
Baseline characteristics of the study population. A total
of 840 residents of Olmsted County, whose mean age was
75  7 years (range, 65 to 100 years), met all study criteria.
Of these, 325 (39%) were men with a mean age of 73  6
years, and 515 were women with a mean age of 76 7 years
(p  0.001). The primary indications for echocardiographic
assessment were dyspnea (30%), chest discomfort (22%),
palpitations, light-headedness, presyncope or syncope
(18%), cardiac function assessment (22%), murmurs (7%),
and other reasons (1%). Patients who developed NVAF
after baseline echocardiography were more likely to have
had a history of prior hypertension, MI, CAD, CHF (Table
1), mitral annular calcification, larger LV end-diastolic
dimension, greater posterior LV wall thickness, greater LV
mass (indexed by height), lower LV ejection fraction, lower
LV fractional shortening, larger LA dimension, and larger
LA volume (Table 2). At baseline, 138 patients (16%) were
considered to have a normal diastolic function profile, 428
Figure 1. Age-adjusted cumulative survival without nonvalvular atrial fibrillation (NVAF) by left atrial volume indexed to body surface area (LAVI).
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(51%) demonstrated abnormal relaxation, 222 (26%) ful-
filled the criteria for pseudonormal LV filling, and 52 (6%;
percentages add to 100 due to rounding) had restrictive
diastolic physiology. The mean absolute (and indexed) LA
volumes for patients with normal, abnormal relaxation,
pseudonormal, and restrictive diastolic filling were 41  8
ml (22  4 ml/m2), 60  22 ml (33  12 ml/m2), 73  20
ml (41  10 ml/m2), and 81  38 ml (47  22 ml/m2),
respectively.
Predictors of NVAF. A total of 80 patients (9.5%) devel-
oped newly diagnosed, electrocardiographically confirmed,
NVAF during a mean follow-up of 4.1  2.7 years for the
cohort. The average time from echocardiogram to NVAF
was 3.0  2.4 years. The significant age- and gender-
adjusted predictors of NVAF are shown in Table 3. In a
multivariate clinical model, age, prior history of MI, and
history of CHF were independent predictors of NVAF,
while a prior history of hypertension or diabetes mellitus
Figure 2. Age-adjusted cumulative survival without nonvalvular atrial fibrillation (NVAF) by diastolic function profile.
Figure 3. Predictive power of four models (clinical with only clinical risk factors, clinical and left atrial [LA] volume, clinical and diastolic function profile,
and clinical with LA volume and diastolic function profile) for nonvalvular atrial fibrillation.
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was not (Table 4). Gender was not a significant predictor
when adjusted for age alone (Table 3), or in any of the
multivariate models (Table 4).
After adjusting for age, larger LA volume was associated
with increased risk of NVAF (Fig. 1). After adjusting for
multiple clinical risk factors, LA volume remained incre-
mental to a prior history of CHF and MI for the prediction
of NVAF (per log: HR, 3.51; 95% CI, 1.94 to 6.35; p 
0.001) (Table 4).
The presence and severity of diastolic dysfunction were
independently associated with higher risk of NVAF. Ab-
normal relaxation, pseudonormal, and restrictive diastolic
filling were associated with HRs of 3.33 (95% CI, 1.50 to
7.40; p  0.003), 4.84 (95% CI, 2.05 to 11.40; p  0.001),
and 5.26 (95% CI, 2.30 to 12.03; p  0.001), respectively,
when compared with normal diastolic function in the same
model, unadjusted for other factors. When adjusted for age
and gender (Table 3), and after adjustments for clinical risk
factors or LA volume (Table 4), diastolic dysfunction
remained independently predictive of subsequent NVAF.
Table 1. Baseline Clinical Characteristics of Study Population According to NVAF Status at
Follow-Up
Characteristics NVAF (n  80) No NVAF (n  760) p Value
Age, mean  SD, yr 75.9  7 74.5  7 0.062
Men, % 39 33 0.232
Weight, mean  SD, kg 76  18 74  16 0.600
Body surface area, mean  SD, m2 1.8  0.2 1.8  0.2 0.929
Body mass index, mean  SD, kg/m2 28  6 27  5 0.131
Pulse rate, mean  SD, beats/min 71  15 70  12 0.724
SBP, mean  SD, mm Hg 145  27 141  22 0.254
DBP, mean  SD, mm Hg 76  15 77  12 0.854
Height, mean  SD, cm 164  10 165  10 0.259
History of hypertension, % 67.5 54.3 0.024
History of CAD, % 22.5 13.6 0.030
History of myocardial infarction, % 30.0 14.9  0.001
History of congestive heart failure, % 23.8 8.2  0.001
History of carotid artery disease, % 6.3 8.3 0.525
History of peripheral vascular disease, % 16.3 15.7 0.890
History of hyperlipidemia, % 41.3 40.3 0.864
History of diabetes mellitus, % 15.0 10.7 0.239
History of present or past smoking, % 46.3 48.4 0.712
Family history of CAD, % 37.5 36.8 0.908
History of COPD, % 16.3 15.7 0.890
Left ventricular hypertrophy on ECG, % 8.8 4.2 0.087
CAD  coronary artery disease; COPD  chronic obstructive pulmonary disease; DBP  diastolic blood pressure; ECG 
electrocardiogram; NVAF  nonvalvular atrial fibrillation; SBP  systolic blood pressure.
Table 2. Baseline Echocardiographic Characteristics of Study Population According to NVAF
Status at Follow-Up*
Characteristics NVAF (n  80) No NVAF (n  760) p Value
M-mode LA dimension, mm 44  7 41  6  0.001
LA volume, ml 75  26 60  24  0.001
Indexed LA volume, ml/m2 41  13 33  13  0.001
Log LA volume, ml 4.3  0.32 4.0  0.36  0.001
LV end-systolic dimension, mm 31  8 30  7 0.187
LV end-diastolic dimension, mm 51  7 48  6 0.016
LV septal wall thickness, diastolic, mm 11.5  1.8 11.2  2.2 0.147
LV posterior wall thickness, diastolic, mm 10.9  1.6 10.6  1.9 0.019
Indexed LV mass by height, g/m 133  30 117  37 0.008
LV ejection fraction, % 57  14 60  11 0.039
LV fractional shortening, % 35  10 38  8 0.039
LV stroke volume, ml 76  18 77  18 0.960
Cardiac index, l/min/m2 2.92  0.72 2.95  0.78 0.990
Mitral annular calcification, % 24 12 0.002
Mitral inflow peak E velocity, m/s 0.75  0.23 0.71  0.20 0.290
Mitral inflow peak A velocity, m/s 0.84  0.25 0.84  0.24 0.858
Mitral E/A 0.96  0.46 0.89  0.36 0.363
Mitral DT, ms 242  68 231  53 0.172
Tricuspid regurgitation velocity, m/s 2.60  0.72 2.60  0.36 0.920
*Values are mean  SD unless otherwise indicated.
DT  deceleration time; LA  left atrial; LV  left ventricular; NVAF  nonvalvular atrial fibrillation.
1640 Tsang et al. JACC Vol. 40, No. 9, 2002
Nonvalvular AF November 6, 2002:1636–44
Kaplan-Meier five-year age-adjusted cumulative risks of
NVAF were 1%, 12%, 14%, and 21% for patients with
normal, abnormal relaxation, pseudonormal, and restrictive
LV diastolic filling, respectively (Fig. 2).
Systolic function, measured by ejection fraction as a
continuous variable, was a significant predictor of NVAF
when adjusted for age and gender (Table 3), but not after
adjusting for multiple clinical risk factors (Table 4). The
predictive power for NVAF, based on global model chi-
square value, was improved significantly with the addition of
the diastolic function profile to clinical risk factors alone.
The predictive value increased further when LA volume was
added to the model. The predictive power of the model
containing only clinical risk factors and LA volume com-
pared favorably with that containing clinical risk factors and
diastolic function profile (Fig. 3).
DISCUSSION
Diastolic dysfunction as a predictor of first documented
NVAF. This study demonstrated that the presence of
diastolic dysfunction was associated with increased risk of
NVAF in this elderly cohort referred for echocardiography.
Furthermore, the gradient of risk appeared to be related to
the severity of diastolic dysfunction. A decrease in diastolic
performance with advancing age is well documented and has
been regarded as part of “normative” aging (17,18). Our
data challenges the concept that changes in diastolic func-
tion are “normal for age,” as even a mild degree of diastolic
Table 3. Predictors of NVAF, Adjusted for Age and Gender
Variables*
Hazard Ratio
(95% CI) p Value
Age, per year‡ 1.03 (1.01–1.07) 0.050
Male gender† 0.90 (0.56–1.45) 0.662
Body mass index 1.04 (1.00–1.08) 0.044
History of hypertension 1.59 (0.99–2.56) 0.053
History of congestive heart failure 3.75 (2.19–6.40)  0.001
History of myocardial infarction 2.78 (1.71–4.51)  0.001
History of coronary artery disease 2.09 (1.21–3.59) 0.008
History of diabetes mellitus 1.90 (1.03–3.54) 0.042
LA dimension, per 5 mm 1.48 (1.24–1.78)  0.001
LA volume, per log 4.43 (2.55–7.67)  0.001
Indexed LA volume, per 10 ml/m2 1.23 (1.12–1.36)  0.001
LV end-systolic dimension, per 5 mm 1.22 (1.02–1.46) 0.031
LV end-diastolic dimension, per 5 mm 1.41 (1.15–1.74) 0.001
LV ejection fraction, per 10% 0.76 (0.63–0.91) 0.003
LV fractional shortening, per 5% 0.83 (0.73–0.94) 0.004
LV mass indexed by height, g/m 1.01 (1.00–1.02) 0.014
Mitral peak E velocity, 0.2 m/s 6.69 (0.72–61.92) 0.094
Mitral E/A 1.53 (1.00–2.36) 0.053
Abnormal LV diastolic relaxation‡ 2.89 (1.28–6.51) 0.010
Pseudonormal LV filling‡ 4.60 (1.94–10.90)  0.001
Restrictive LV diastolic filling‡ 4.50 (1.92–10.38)  0.001
*p  0.1 for the following variables: systolic blood pressure, diastolic blood pressure,
pulse rate, pulse pressure, body surface area, hyperlipidemia, carotid artery disease,
smoking, chronic obstructive pulmonary disease, LV stroke volume, cardiac index,
tricuspid regurgitation velocity, and mitral A velocity; †age was adjusted for gender
only, and gender was adjusted for age only; ‡age- and gender-adjusted model with all
three diastolic function categories in the model.
CI  confidence interval; LA  left atrial; LV  left ventricular; NVAF 
nonvalvular atrial fibrillation.
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dysfunction, such as abnormal relaxation, more than tripled
the likelihood of developing the adverse outcome of AF.
Moreover, this occurred over a relatively short follow-up
period of approximately four years.
Diastolic dysfunction has also been shown to be largely
responsible for approximately one-half of all new cases of
CHF in the Framingham study (19) and in an Olmsted
County study (20). The ability to detect diastolic abnormal-
ities has been made possible by the introduction of Doppler
echocardiography in the 1980s (21,22), and various sophis-
ticated techniques for increasingly precise assessment of
diastolic function have been developed since then. Simple
transmitral flow characteristics, however, remain central to
the evaluation of diastolic function and provide important
prognostic information (23–25). In this study a simple
diastolic function profile using only mitral DT, mitral E/A,
and LA volume allowed a meaningful stratification of risk
for subsequent NVAF. The diastolic function profile was
incremental to clinical risk factors and LA volume for such
prediction (Table 4, Fig. 3).
LA volume as a predictor of NVAF. As in the Framing-
ham Heart study (26) and the Cardiovascular Health study
(27), M-mode LA dimension was also found to predict the
development of NVAF in this study. Each 5-mm-larger LA
dimension was associated with an increase in risk of 48%
(Table 3). Left atrial volume provides a more sensitive
assessment of LA enlargement (28), and, as we have shown
previously, it is an important independent predictor of AF,
providing incremental information beyond that afforded by
the clinical risk factors and conventional M-mode LA
dimension (29). In our previous study, patients with valvular
heart disease, a strong determinant of AF, were not ex-
cluded. In the current study, LA volume was confirmed to
be independent of both clinical risk factors and diastolic
function profile for the prediction of AF in the absence of
valvular heart disease (Table 4). The data suggested that the
larger the LA volume, the greater the risk of NVAF (Table
3, Fig. 1).
The importance of LA volume as a predictor of NVAF
was underscored by the finding that the predictive value was
enhanced further by the addition of LA volume to the
model that already included clinical risk factors and the
diastolic function profile (Fig. 3). The model based only on
clinical risk factors and LA volume compared favorably with
that containing clinical risk factors and diastolic function
profile. These findings lend support to the contention that
LA volume is a robust barometer of diastolic filling abnor-
malities (16). While transmitral flow indexes provide im-
portant information on diastolic function, they are known to
be load-dependent (21). Although speculative at this point,
it is possible that the relationship between transmitral
inflow characteristics and LA volume may be analogous to
that between serum glucose and glycosylated hemoglobin.
Left atrial volume may provide a measure of chronicity, and
not just severity of diastolic dysfunction, and the chronicity
may, in turn, reflect the extent of alterations in the atrial
substrate predisposing to electrophysiologic abnormalities
and development of arrhythmia.
Clinical risk factors for predicting NVAF. The incidence
of NVAF in this referral study population was 23.2 per
1,000 person-years. This was, as expected, higher than that
identified in the Cardiovascular Health study of randomly
selected community members who were 65 years or older
and fulfilled Medicare eligibility (19.2 per 1,000 person-
years) (27). In both studies there was a predominance of
women (Olmsted referral study, 61%; Cardiovascular
Health study, 57%). Like other investigators (26,27), we
found certain clinical variables to be important predictors of
NVAF (Tables 3 and 4). However, in contrast, we found
that hypertension was not independently significant after
adjusting for multiple factors. That hypertension did not
retain independent significance could reflect the high prev-
alence of the condition in this cohort at baseline. In
addition, unlike some studies, male gender was not an
independent predictor. The reason for this finding is uncer-
tain, although our cohort did include a greater proportion of
women than some other populations that have been studied.
Our study, however, demonstrated that the inclusion of LA
volume and the diastolic function profile significantly aug-
mented the predictive value of models based on clinical risk
factors alone (Fig. 3).
Mechanism for diastolic dysfunction as a precursor for
the development of NVAF. In this study of older adults,
even a milder form of diastolic dysfunction, namely, abnor-
mal relaxation, appeared to increase the propensity for
NVAF, independent of the effects of age. Skubas et al. (30)
reported that diastolic relaxation abnormalities were highly
prevalent in patients presenting for the Maze procedure. It
is conceivable that LV relaxation abnormalities lead to a
reduction in passive LA emptying, with the development of
higher atrial pressures during atrial diastole. This, in turn,
may result in a larger LA volume at the onset of atrial
systole, with enhanced atrial ejection occurring as a com-
pensatory response (31). Over time, the LA and pulmonary
veins dilate. The distention and stretching of these struc-
tures may potentiate electrical remodeling, with shortening
of the atrial effective refractory period (32) or an increase in
dispersion of refractoriness, resulting in vulnerability to AF
(33,34).
Both passive atrial stretch and an increase in atrial
pressure during atrial contraction have been found to
stimulate the release of atrial natriuretic factor (35). In
addition, Grandi et al. (36) demonstrated that diastolic
impairment is the main influence on the levels of atrial
natriuretic factor in patients with mild hypertension. In one
study the level of atrial natriuretic factor was found to be a
predictor of paroxysmal AF (37). Thus, the relationship
between diastolic abnormalities and the development of
NVAF may be mediated through an increase in atrial
pressure, atrial stretch, and neurohormonal activation, in-
cluding the release of atrial natriuretic factor.
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Study limitations. The clinical data for this study were
obtained by retrospective chart review; therefore, certain
inherent biases are possible. The method of ascertainment
of AF, based on clinical documentation with electrocardio-
graphic confirmation, could have underestimated the actual
number of incident AF cases. For instance, some patients
with AF could have been asymptomatic, and if they did not
present to the medical system for other reasons, the arrhyth-
mia could have remained undetected for some time. How-
ever, it was previously established that 96% of Olmsted
County residents aged 65 to 74 years had at least one
encounter with the Mayo medical system within a three-
year period (11). For simplicity, we used mitral inflow
characteristics and LA volume in the construction of a
diastolic function profile for prediction of the outcome event
of NVAF. It is recognized that more refined discrimination
of categories of diastolic dysfunction can be achieved if
additional assessments, including pulmonary venous flow,
color M-mode, and tissue Doppler imaging techniques, are
also used. However, given the study period being 1990 to
1998, pulmonary venous flow measurements were not avail-
able in a considerable number of studies during the earlier
half of the period, and tissue Doppler assessments did not
become part of routine standard echocardiogram study until
1999. Color M-mode was used only selectively during this
period of time. Because all subjects were patients referred
for echocardiographic assessment at Mayo Clinic or Olm-
sted Medical Center, the extent to which the findings can be
generalized to the rest of Olmsted County residents and to
non-Olmsted residents is unknown. The population studied
was predominantly white, and whether similar findings can
be identified in other racial groups needs to be verified in
future studies.
Conclusions. Diastolic dysfunction appears to be a potent
precursor of NVAF in the elderly, with an independent,
graded relationship between the severity of diastolic dys-
function and the development of NVAF. These findings
provide a foundation for further investigation into the links
between age, diseased atrial substrate, electrophysiologic
remodeling, and subsequent AF, as well as a compelling
rationale for search of effective approaches to prevent and
reverse diastolic dysfunction, which may have far-reaching
public health consequences.
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